GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » CardioGenics Holdings Inc (OTCPK:CGNH) » Definitions » Float Percentage Of Total Shares Outstanding

CardioGenics Holdings (CardioGenics Holdings) Float Percentage Of Total Shares Outstanding : 92.67% (As of Jun. 07, 2024)


View and export this data going back to 2004. Start your Free Trial

What is CardioGenics Holdings Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, CardioGenics Holdings's float shares is 89.01 Mil. CardioGenics Holdings's total shares outstanding is 96.05 Mil. CardioGenics Holdings's float percentage of total shares outstanding is 92.67%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, CardioGenics Holdings's Insider Ownership is 11.69%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, CardioGenics Holdings's Institutional Ownership is 0.18%.


CardioGenics Holdings Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

CardioGenics Holdings's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=89.01/96.05
=92.67%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CardioGenics Holdings (CardioGenics Holdings) Business Description

Traded in Other Exchanges
N/A
Address
6295 Northam Drive, Unit 8, Mississauga, ON, CAN, L4V 1W8
CardioGenics Holdings Inc is a biotechnology company. It is engaged in the development and commercialization of diagnostic test products for the In-Vitro Diagnostics (IVD) testing market. The company's objective is to create, develop and commercialize superior, innovative, cost-effective and patent-protected products for the IVD based on proprietary technologies. Its products include QL Care Analyzer, Immunoassay Tests, and Paramagnetic Beads. The business activity is primarily carried out through the region of Canada.

CardioGenics Holdings (CardioGenics Holdings) Headlines

No Headlines